Optimising management of stroke and bleeding in atrial fibrillation

25 Nov 2024
Optimising management of stroke and bleeding
in atrial fibrillation
An expert panel converged to discuss the nuances of managing and achieving balance in stroke and bleeding among patients with atrial fibrillation at the recent Boehringer Ingelheim sponsored Stroke Prevention in Atrial Fibrillation (SPAF) Forum 2024.
Sponsored as an educational program by Boehringer Ingelheim (Malaysia) Sdn Bhd.

Related MIMS Drugs

Resources

MY-BOE-138

MY-BOE-138

MY-BOE-138

MY-BOE-138